advertisement
Berdahl JP 200
Showing records 1 to 25 | Display only abstracts from Berdahl JP in IGR 15-2124893 Long-Term Safety and Efficacy Evaluation of Travoprost Intracameral Implant Based on Pooled Analyses from Two Phase III Trials
Singh IP
Drugs 2024; 84: 1299-1311 (IGR: 25-1)
122987 Application of Negative Pressure by the Ocular Pressure Adjusting Pump to Provide a Sustained Reduction in IOP
Ferguson TJ
Clinical Ophthalmology 2024; 18: 3171-3178 (IGR: 25-1)
124893 Long-Term Safety and Efficacy Evaluation of Travoprost Intracameral Implant Based on Pooled Analyses from Two Phase III Trials
Berdahl JP
Drugs 2024; 84: 1299-1311 (IGR: 25-1)
122987 Application of Negative Pressure by the Ocular Pressure Adjusting Pump to Provide a Sustained Reduction in IOP
Herndon LW
Clinical Ophthalmology 2024; 18: 3171-3178 (IGR: 25-1)
124893 Long-Term Safety and Efficacy Evaluation of Travoprost Intracameral Implant Based on Pooled Analyses from Two Phase III Trials
Sarkisian SR
Drugs 2024; 84: 1299-1311 (IGR: 25-1)
122987 Application of Negative Pressure by the Ocular Pressure Adjusting Pump to Provide a Sustained Reduction in IOP
Terveen DC
Clinical Ophthalmology 2024; 18: 3171-3178 (IGR: 25-1)
124893 Long-Term Safety and Efficacy Evaluation of Travoprost Intracameral Implant Based on Pooled Analyses from Two Phase III Trials
Voskanyan LA
Drugs 2024; 84: 1299-1311 (IGR: 25-1)
122987 Application of Negative Pressure by the Ocular Pressure Adjusting Pump to Provide a Sustained Reduction in IOP
Shah M
Clinical Ophthalmology 2024; 18: 3171-3178 (IGR: 25-1)
124893 Long-Term Safety and Efficacy Evaluation of Travoprost Intracameral Implant Based on Pooled Analyses from Two Phase III Trials
Ang RE
Drugs 2024; 84: 1299-1311 (IGR: 25-1)
122987 Application of Negative Pressure by the Ocular Pressure Adjusting Pump to Provide a Sustained Reduction in IOP
Samuelson TW; Yoo P
Clinical Ophthalmology 2024; 18: 3171-3178 (IGR: 25-1)
124893 Long-Term Safety and Efficacy Evaluation of Travoprost Intracameral Implant Based on Pooled Analyses from Two Phase III Trials
Doan LV; Doan LV; Applegate D
Drugs 2024; 84: 1299-1311 (IGR: 25-1)
122987 Application of Negative Pressure by the Ocular Pressure Adjusting Pump to Provide a Sustained Reduction in IOP
Berdahl JP
Clinical Ophthalmology 2024; 18: 3171-3178 (IGR: 25-1)
124893 Long-Term Safety and Efficacy Evaluation of Travoprost Intracameral Implant Based on Pooled Analyses from Two Phase III Trials
Shen Y; Katz LJ; Kothe AC; Navratil T
Drugs 2024; 84: 1299-1311 (IGR: 25-1)
116785 Efficacy and Safety of the Travoprost Intraocular Implant in Reducing Topical IOP-Lowering Medication Burden in Patients with Open-Angle Glaucoma or Ocular Hypertension
Berdahl JP
Drugs 2024; 84: 83-97 (IGR: 24-4)
117190 Phase 3 Randomized Clinical Trial of the Safety and Efficacy of Travoprost Intraocular Implant in Patients with Open-Angle Glaucoma or Ocular Hypertension
Sarkisian SR
Ophthalmology 2024; 131: 1021-1032 (IGR: 24-4)
117280 Superonasal vs Inferonasal Subconjunctival Gel Stent Placement in Patients with Glaucoma
Vander Zee BL; Wilson C
Journal of Current Glaucoma Practice 2024; 18: 63-67 (IGR: 24-4)
116785 Efficacy and Safety of the Travoprost Intraocular Implant in Reducing Topical IOP-Lowering Medication Burden in Patients with Open-Angle Glaucoma or Ocular Hypertension
Sarkisian SR
Drugs 2024; 84: 83-97 (IGR: 24-4)
117190 Phase 3 Randomized Clinical Trial of the Safety and Efficacy of Travoprost Intraocular Implant in Patients with Open-Angle Glaucoma or Ocular Hypertension
Ang RE; Lee AM
Ophthalmology 2024; 131: 1021-1032 (IGR: 24-4)
117280 Superonasal vs Inferonasal Subconjunctival Gel Stent Placement in Patients with Glaucoma
Berdahl JP
Journal of Current Glaucoma Practice 2024; 18: 63-67 (IGR: 24-4)
116785 Efficacy and Safety of the Travoprost Intraocular Implant in Reducing Topical IOP-Lowering Medication Burden in Patients with Open-Angle Glaucoma or Ocular Hypertension
Ang RE; Doan LV
Drugs 2024; 84: 83-97 (IGR: 24-4)
117190 Phase 3 Randomized Clinical Trial of the Safety and Efficacy of Travoprost Intraocular Implant in Patients with Open-Angle Glaucoma or Ocular Hypertension
Berdahl JP
Ophthalmology 2024; 131: 1021-1032 (IGR: 24-4)
116785 Efficacy and Safety of the Travoprost Intraocular Implant in Reducing Topical IOP-Lowering Medication Burden in Patients with Open-Angle Glaucoma or Ocular Hypertension
Doan LV
Drugs 2024; 84: 83-97 (IGR: 24-4)
117280 Superonasal vs Inferonasal Subconjunctival Gel Stent Placement in Patients with Glaucoma
Terveen D
Journal of Current Glaucoma Practice 2024; 18: 63-67 (IGR: 24-4)
116785 Efficacy and Safety of the Travoprost Intraocular Implant in Reducing Topical IOP-Lowering Medication Burden in Patients with Open-Angle Glaucoma or Ocular Hypertension
Kothe AC
Drugs 2024; 84: 83-97 (IGR: 24-4)
117280 Superonasal vs Inferonasal Subconjunctival Gel Stent Placement in Patients with Glaucoma
Ferguson TJ
Journal of Current Glaucoma Practice 2024; 18: 63-67 (IGR: 24-4)
